Julie Rehmeyer's 'Through the Shadowlands'
Writer Never Give Up talks about Julie Rehmeyer's new book "Through the Shadowlands: A Science Writer's Odyssey into an Illness Science Doesn't Understand" and shares an interview with Julie ...
Discuss the article on the Forums.

Phase 3 Norwegian trials

Discussion in 'Rituximab: News and Research' started by neweimear, Jun 12, 2017.

  1. neweimear

    neweimear Senior Member

    Messages:
    114
    Likes:
    341
    Does anyone have any idea how long it will be from October 2018 when the phase 3 Norwegian trials conclude until the results are published?
     
  2. Jo Best

    Jo Best Senior Member

    Messages:
    985
    Likes:
    6,071
    Do you mean October 2017 when the results will be unblinded?
     
  3. BurnA

    BurnA Senior Member

    Messages:
    2,086
    Likes:
    9,846
    Personal guess would be 3-6 months.
    But it's a guess.
     
  4. neweimear

    neweimear Senior Member

    Messages:
    114
    Likes:
    341
    Yes I meant October 2017....sorry!
     
  5. TrixieStix

    TrixieStix Senior Member

    Messages:
    507
    Likes:
    850
    I think I remember someone saying they figured it would be about June (2018) or so
     
  6. Londinium

    Londinium Senior Member

    Messages:
    153
    Likes:
    1,300
    That seems reasonable. 3-6 months for peer review, going by the 'date accepted' vs. 'date published' on similar papers. If unblinding is in October, add a few months for the data to be analysed and the paper to be drafted, so June next year seems about right. Hopefully we'd get some hints before then (e.g. if we see all systems go on the UK trial, that might suggest promising unpublished results).
     
    Jo Best, TrixieStix and BurnA like this.

See more popular forum discussions.

Share This Page